Sat.Oct 03, 2020 - Fri.Oct 09, 2020

article thumbnail

Pharma’s digital transformation journey and the role of customer reference data

pharmaphorum

Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. pharmaphorum’s Richard Staines spoke to her about how the use of customer reference data can transform pharma companies, increase competitiveness, and benefit the bottom line during these challenging times. Precision medicine is emerging as a key approach for disease treatment and prevention, which makes it even more critical to get the right medicine to the

article thumbnail

Clinical trials have ‘much work to do’ in boosting diversity

Outsourcing Pharma

A veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.

134
134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lansoprazole vs Omeprazole: differences and similarities

Druggist

In today’s post, I will contrast the two most popular proton pump inhibitors (PPIs) prescribed in the UK. Not only lansoprazole and omeprazole are the two most common PPI, but they are also one of the most popular prescribed drugs in the UK. I will review the essential facts to highlight the similarity and difference between each medication. Lansoprazole vs omeprazole – post summary: Lansoprazole vs omeprazole: drug classification Lansoprazole vs omeprazole: mechanism of action Lansoprazol

article thumbnail

Perspectives on a Post-pandemic World

Pharma Marketing Network

An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Your.MD secures $30m to expand self-care app Healthily

pharmaphorum

Digital health firm Your.MD has secured $30 million in a Series A round investment led by the consumer health giant Reckitt Benckiser (RB). Your.MD is the company behind the medical-grade, augmented intelligence self-care app Healthily, and will use the funding to accelerate the platform through a series of clinically-validated “health hubs”. Following a seed funding round led by RB and existing shareholders, the now completed Series A funding round will allow the app to reach other markets incl

124
124
article thumbnail

People on the Move: October 2020

Outsourcing Pharma

The latest news on pharmaceutical industry hires, promotions, acquititions and other events includes Medable, Eversana, Parexel, Astellas and more.

98

More Trending

article thumbnail

Perspectives on a Post-pandemic World

Pharma Marketing Network

An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.

article thumbnail

Why intelligent automation is the future for regulation

pharmaphorum

There are a host of new, previously unimaginable tools and techniques – from analytics to robotic process automation (RPA) and artificial intelligence (AI) – available to help speed up processes and increase data accuracy. But for many life sciences organisations, these tools are either not yet fully adopted or are not being put to good use within their regulatory functions.

article thumbnail

Premier Research: holistic approach benefits drug development

Outsourcing Pharma

A leader from the CRO shares insights as to what strategies and philosophies work best when working to craft a successful drug development program.

98
article thumbnail

How is Cell Isolation Revolutionizing Medical Industry?

Pharma Mirror

One of the biggest medical advancements of recent times is the invention of the cell isolation method. Also known as cell sorting or cell separation, the cell isolation method has rapidly become an integral component of modern biological and medical research. In this method, a one-cell population or multiple cell types are isolated from a. The post How is Cell Isolation Revolutionizing Medical Industry?

64
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Maintaining Both Your Business and Your Sanity During the Pandemic

Pharma Marketing Network

Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.

article thumbnail

Older people first to receive COVID-19 vaccine in UK, says government

pharmaphorum

As European regulators begin a rolling review of AstraZeneca’s COVID-19 vaccine, the focus in the UK has shifted to the government’s plans to distribute any vaccine that is deemed to be a safe and effective way of preventing the disease. According to weekend press reports a rollout of a vaccine could be just three months away – but the feedback from the government is that not everyone will get it, with the target group being around 30 million older people and health workers, less than half the p

Vaccines 111
article thumbnail

Clinical trial volume, variety drive data solutions

Outsourcing Pharma

eClinical, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products.

85
article thumbnail

EMA accepts filing for Biogen/Samsung Bioepis’ Lucentis biosimilar

Pharma Times

Biosimilar is an anti-VEGF therapy for retinal vascular disorders

61
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Maintaining Both Your Business and Your Sanity During the Pandemic

Pharma Marketing Network

Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.

article thumbnail

Flying the flag for research in Aarskog syndrome

pharmaphorum

Delayed diagnosis, lack of awareness, and a limited evidence base – Aarskog syndrome faces all the challenges of rare diseases everywhere. But a new study hopes to kick start a revolution in understanding. For five years, Michelle Erskine faced a succession of closed doors and disbelief as she struggled to convince someone that all was not well with her son.

111
111
article thumbnail

Investors bet on decentralized trial technology

Outsourcing Pharma

Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials.

72
article thumbnail

London universities join forces to ramp up COVID-19 testing

Pharma Times

Testing Alliance created to offer 20,500 extra coronavirus tests a day

54
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Romaco implements new sustainability strategy

Pharma Mirror

Romaco has appointed a Sustainability Officer and defined goals for the company’s climate-friendly development. Not only is the manufacturer seeking to enable more sustainable production by its customers; Romaco is also keen to improve its own carbon footprint. The Romaco Group has a new central corporate objective: sustainability. To enable climate protection measures to be.

52
article thumbnail

EU ramps up supply of COVID-19 vaccine, drugs

pharmaphorum

The European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after signing a supply deal for up to 400 million doses of Johnson & Johnson’s experimental candidate. The agreement is the third for coronavirus vaccine supply for the EU, coming after earlier deals with AstraZeneca and Sanofi/GlaxoSmithKline, and comes as wealthy nations are scrambling to secure access to the initial supplies of the shots furthest ahead in development.

Vaccines 105
article thumbnail

First patient dosed in long-term Alzheimer’s trial

Outsourcing Pharma

Neurotrope has kicked off its ongoing Phase II study of Bryostatin-1 for treatment of Alzheimerâs disease, with the help of a $2.7m NIH grant.

60
article thumbnail

Neuroblastoma UK welcomes advancement of potential new treatment

Pharma Times

Fadraciclib has passed safety trials and shown early efficacy

52
article thumbnail

Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™

Pharma Mirror

Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the market release of SeptiCyte® RAPID on Idylla™ as a CE-marked IVD test. SeptiCyte® RAPID is a host-response test that distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and provides actionable results in about one.

52
article thumbnail

CRISPR pioneers Doudna and Charpentier claim Nobel chemistry prize

pharmaphorum

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently at the Max Planck Unit for the Science of Pathogens in Germany – and Doudna of the University of California, Berkeley (pictured left to right), are the first two women to share the prize awarded by the Royal Swedish Academy of Sciences.

105
105
article thumbnail

CPhI, Pharmapack Europe to return in 2021

Outsourcing Pharma

The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.

52
article thumbnail

Gilead inks supply agreement with the European Commission for remdesivir

Pharma Times

New agreement allows countries in the EU, EEA and the UK to purchase drug

52
article thumbnail

Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events

Pharma Mirror

Informa Markets announces its complete listing of pharma event dates for 2021 at the opening of the first CPhI Festival of Pharma (05 – 16 October 2020) – the largest ever virtual pharma event. The pharma schedule includes one further event in 2020: CPhI China, 16-18 December (hybrid event, combining “live” in-person with “virtual”). In. The post Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events appeared first on Pharma Mirror Magazine.

52
article thumbnail

Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done

pharmaphorum

October is ADHD Awareness Month, and retired NFL linebacker J.T. Thomas wants people to know that it is okay to get help for the treatment of attention deficit hyperactivity disorder (ADHD). As a person with ADHD, J.T. Thomas knows how important getting help is, and why overcoming obstacles such as stigma, access to care and improper diagnosis are so important.

article thumbnail

ATCC lands $250m from BARDA for COVID-19 services

Outsourcing Pharma

The contract, with a ceiling value of $250M and potential length of 10 years, will supplement the companyâs ongoing support of virus-related work.

52
article thumbnail

ViiV’s two-drug HIV regimen demonstrates long-term efficacy

Pharma Times

Two-drug regimen continues to offer non-inferior efficacy compared to a three-drug regimen

52
article thumbnail

Ep. 008 – Vlad Mkrtumyan Podcast Transcript

Pharma Marketing Network

Don ( PMN): Hello everyone thanks for joining us at the Pharma marketing podcast. I’m your host Don Langsdorf our guest today is Vlad Mkrtumyan. He’s a serial entrepreneur, a search engine marketing evangelist and a passionate networker. He’s also responsible for running 5 meet ups including the Seattle Marketing in demand leaders meet up which is the largest marketing meet up in Seattle.

article thumbnail

Roche working “around the clock” to tackle UK test supply problems

pharmaphorum

Supplies of swabs for coronavirus and other critical NHS tests for diseases like cancer, diabetes and heart disease have been threatened by a failure at a facility operated by Roche. The company said the problems – which also include other items like reagents and screening kits – have resulted from a switch to a new warehouse, which ironically is intended to make production quicker and more efficient through the use of automated processes.

72
article thumbnail

FDA COVID-19 response roundup

Outsourcing Pharma

As the pandemic maintains its hold, the US agency continues to issue advice and take action related to testing, treatment and information on the virus.

FDA 52